TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device ...

CALGARY, AB, April 14, 2025 /CNW/ - Expander Energy Inc. ("Expander"), is pleased to announce that Expander intends to proceed with the Carseland Bio-Synfuels project. Cielo Waste Solutions Corp.

Burlington, Ontario--(Newsfile Corp. - April 14, 2025) - Silver Bullet Mines Corp. (TSXV: SBMI) (OTCQB: SBMCF) ('SBMI' or 'the Company') is very pleased to report it has signed an open purchase ...

BOU-MP24-010 intercepted 371 g/t AgEq over 1.0m (4.01 g/t Au, 20 g/t Ag, 0.9% Zn, 0.6% Pb and 0.03% Cu) and 208 g/t AgEq over 2.0m (0.91 g/t Au, 44 g/t Ag, 2.5% Zn, 1.0% Pb and 0.1% Cu) Identification ...

Toronto, Ontario--(Newsfile Corp. - April 14, 2025) - Theralase® Technologies Inc. (TSXV: TLT)(OTCQB: TLTFF) ("Theralase®" or the "Company"), a ...

VANCOUVER, BC, April 14, 2025 /CNW/ - Liberty Gold Corp. (TSX: LGD) (OTCQX: LGDTF) ("Liberty Gold" or the "Company") is pleased to announce that it has entered into an agreement with Canaccord Genuity ...

3.1m of 19.4 g/t Au, within 106.6m of 0.6 g/t Au (JES-24-101) 16.8m of 0.4 g/t Au and 6 g/t Ag (JES-24-102) "We are excited to be back drilling the expansion zone where recent results returned ...

Neil E. Hide brings a wealth of expertise in the digital display landscape to his new role at Metavista3D. His prior experience includes leadership positions such as Vice President Automotive at ...

Johannesburg, South Africa--(Newsfile Corp. - April 7, 2025) - Ivanhoe Mines' (TSX: IVN) (OTCQX: IVPAF) Executive Co-Chair Robert Friedland and President & Chief Executive Officer Marna Cloete ...

Cal Everett and Greg Etter from Liberty Gold’s board of directors have agreed to join the board of Specialty American and suitable independent candidates have been identified for the ...

Note: Reported intervals are drilled core lengths and do not indicate true widths. True widths are estimated at between 80-100% of core length. For duplicate samples, the original sample assays are ...

Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus FDA-approved, standard of care treatments Acyclovir and Abreva in a preclinical animal model. In the ...